FDA’s Real-World Evidence Framework Is Out. Now What?

December 12, 2018

Drug companies could rewrite their playbooks for demonstrating how well their medicines work under a new Food and Drug Administration (FDA) blueprint on how it will accept analyses of routine health data.

Related Stories